Here's Why Sarepta (SRPT) Stock Price Surged 57% YTD

Yahoo FinanceJul 8 12:04 ET

Regenxbio(RGNX.US) Director Sells US$112.69K in Common Stock

$Regenxbio(RGNX.US)$ Director KARABELAS ARGERIS N sold 10,000 shares of common stock on Jul 1, 2024 at an average price of $11.2691 for a total value of $112.69K.Source: Announcement What is statement

Moomoo NewsJul 3 08:38 ET

Why Did Analysts Maintain a Bullish Stance on REGENXBIO Inc. (RGNX) Despite Decline In Its Revenue Growth?

Yahoo FinanceJun 27 10:05 ET

Why Is Clearside Biomedical Stock Gaining Today?

Oppenheimer initiated coverage on Clearside Biomedical Inc (NASDAQ:CLSD), a biopharmaceutical company focused on delivering therapies to the back of the eye through the suprachoroidal (SCS) space.Oppe

BenzingaJun 25 12:54 ET

Regenxbio (RGNX) Soars 6.4%: Is Further Upside Left in the Stock?

Yahoo FinanceJun 25 04:32 ET

Regenxbio Enrolling New Group for Phase 1/2 Duchenne Muscular Dystrophy Trial

Regenxbio (RGNX) said Monday that it started the enrollment of a new group of patients aged 1 year to 3 years old for the phase 1/2 trial of RGX-202 in boys with Duchenne muscular dystrophy. The compa

MT NewswiresJun 24 11:58 ET